ClinicalTrials.govpublic full text
Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
chronic lymphocytic leukemia (cll), small lymphocytic lymphoma, monoclonal antibody therapy, biologic response modifier therapy, cll, sll, chemo-care (cc) 5013- revlimid, chronic lymphocytic leukemia, small lymphocytic leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030566
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.